1.Gastro-Colo-Cutaneous Fistula Occurring After Percutaneous Endoscopic Gastrostomy Procedure
Juyung JOUNG ; Jeeyeon BAEK ; Sun Hyung KANG ; Hee Seok MOON ; Jae Kyu SUNG ; Hwan Jung YUN
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2024;24(1):72-76
An 82-year-old man diagnosed with supraglottic cancer sought a consultation for percutaneous endoscopic gastrostomy (PEG) placement. Preoperative chest radiography (posterior-anterior [PA] view) revealed no abnormalities, and PEG tube placement was performed using the “pull” method. Chest radiography (PA view) performed 3 days postoperatively showed free air that was not observed immediately after PEG tube placement; therefore, the patient was diagnosed with pneumoperitoneum. Abdominal computed tomography confirmed that the PEG tube was appropriately positioned within the stomach; however, the colon was observed between the abdominal wall and stomach, which indicated that the PEG tube had passed through the colon. Review of preoperative chest radiographs (PA views) confirmed that the colon was visualized in the area wherein usually stomach gas should have been observed. The patient was diagnosed with a gastro-colo-cutaneous fistula that occurred postoperatively, following a procedure that was performed without confirmation of anatomical variations. The PEG tube was removed surgically, and we performed percutaneous gastrostomy.
2.Increased Interleukin-17 Expression in Patients with Idiopathic Inflammatory Myopathies.
Seung Hoon BAEK ; Jun Hee LEE ; Geun Tae KIM ; Joung Wook LEE ; Mi Ra CHO ; Ju In KIM ; Sun Hee LEE ; Dae Seong KIM ; Sung Il KIM
The Journal of the Korean Rheumatism Association 2008;15(2):118-122
OBJECTIVE: Idiopathic inflammatory myopathies (IIMs) are systemic autoimmune diseases characterized by infiltration of T lymphocytes, monocytes, and macrophages in muscle tissues. Interleukin-17 (IL-17), a Th17 cytokine, has potent pro-inflammatory actions and plays a role in autoimmune diseases. We investigated the expression of IL-17 in muscle tissues of patients with IIMs. METHODS: We measured the IL-17 mRNA level of muscle tissues from 14 patients with IIMs (9 patients with dermatomyositis and 5 patients with polymyositis) by real-time RT-PCR and compared with controls. We also performed an immunohistochemical stain to detect IL-17 expression. RESULTS: The expressions of IL-17 were significantly enhanced in IIMs than controls. In immunohistochemistry, IL-17 was expressed in perimysial, endomysial and perivascular infiltrating inflammatory cells. CONCLUSION: These results suggest that IL-17 plays a role in the immunopathogenesis of IIMs.
3.A Patient with Duodenal Mucinous Adenocarcinoma Presenting as a Laterally Spreading Tumor.
Myung Joon CHAE ; Il Hyun BAEK ; Yu Mi OH ; Jun Uk LIM ; Jung Won JEON ; Hyun Phil SHIN ; Kwang Ro JOO ; Joung Il LEE
Clinical Endoscopy 2015;48(4):336-339
Primary duodenal carcinoma is rare. Duodenal mucinous adenocarcinoma (DMA) is even rarer, and its associated manifestations and typical endoscopic or imaging findings are not well characterized. Herein, we report a case of primary DMA in an asymptomatic 58-year-old man who visited our hospital for a regular health screening. Upper endoscopy revealed an approximately 4-cm lesion in the second portion of the duodenum, but the mass was not visualized on computed tomography. Biopsies revealed a tubular adenoma that was subsequently resected. Frozen biopsies demonstrated DMA with a background of low-grade tubular adenoma for which we performed Roux-en-Y duodenojejunostomy and jejunojejunostomy. To our knowledge, this is the first report of a patient with DMA in Korea.
Adenocarcinoma
;
Adenocarcinoma, Mucinous*
;
Adenoma
;
Biopsy
;
Duodenal Neoplasms
;
Duodenum
;
Endoscopy
;
Humans
;
Korea
;
Mass Screening
;
Middle Aged
4.The Expression of Toll-like Receptors in Idiopathic Inflammatory Myopathies.
Geun Tae KIM ; Jun Hee LEE ; Seung Hoon BAEK ; Joung Wook LEE ; Mi Ra CHO ; Ju In KIM ; Sun Hee LEE ; Dae Seong KIM ; Sung Il KIM
The Journal of the Korean Rheumatism Association 2007;14(2):118-124
Objective: To investigate the expression of toll-like receptor (TLR)-2, 4 and 9 in idiopathic inflammatory myopathies (IIMs). Methods: The expression of TLR-2, 4 and 9 was measured by real-time RT-PCR and immunohistochemical stain (IHS) from muscle tissues in patients with IIMs and controls. Results: The expression levels of TLR-2, 4 and 9 in IIMs were significantly higher than controls. TLR-2, 4 and 9 were mainly expressed on sarcolemma of muscle fibers, perimysial vascular endothelium and infiltrating inflammatory cells in dermatomyositis, whereas, they were mainly expressed on sarcolemma of muscle fibers, destructed muscle fibers, and enodmysial infiltrating inflammatory cells in polymyositis. Conclusion: TLR-2, 4 and 9 were highly expressed in muscle tissue of IIMs. These results suggest that TLR-2, 4 and 9 play a role in pathogenesis of IIMs.
Dermatomyositis
;
Endothelium, Vascular
;
Humans
;
Myositis*
;
Polymyositis
;
Sarcolemma
;
Toll-Like Receptors*
5.A Case of Cavernous Lymphangioma of the Small Bowel Mesentery.
In Taik HONG ; Jae Myung CHA ; Joung Il LEE ; Kwang Ro JOO ; Il Hyun BAEK ; Hyun Phil SHIN ; Jung Won JEON ; Jun Uk LIM
The Korean Journal of Gastroenterology 2015;66(3):172-175
Lymphangioma is a benign vascular lesion with characteristics of subepithelial tumor which can proliferate in the lymphatic system. Lymphangioma of the small-bowel mesentery is rare, having been reported in less than 2% of all lymphangiomas. Lymphangioma does not require any specific treatment because it is absolutely a benign tumor. However, surgical exploration is rarely required for cases with disease-related symptoms or complications, or for those misdiagnosed as a malignant lesion. We recently experienced a case of mesenteric cavernous lymphangomas in a 53-year-old female who was misdiagnosed as having a liposarcoma. The final diagnosis was confirmed by a pathologic examination of the specimen that was obtained via laparoscopic exploration. Herein, we report a very rare case of mesenteric cavernous lymphangioma along with a brief review of relevant literature.
Female
;
Humans
;
Intestine, Small/pathology
;
Laparoscopy
;
Lymphangioma/*diagnosis/pathology/surgery
;
Mesentery/pathology
;
Middle Aged
;
Peritoneal Neoplasms/*diagnosis/pathology/surgery
;
Tomography, X-Ray Computed
6.Long-term follow-up of Fanconi anemia: clinical manifestation and treatment outcome.
Byung Gyu YOON ; Hee Na KIM ; Ui Joung HAN ; Hae In JANG ; Dong Kyun HAN ; Hee Jo BAEK ; Tai Ju HWANG ; Hoon KOOK
Korean Journal of Pediatrics 2014;57(3):125-134
PURPOSE: The aim of this study was to characterize Korean patients with Fanconi anemia (FA), which is a rare but very challenging genetic disease. METHODS: The medical records of 12 FA patients diagnosed at Chonnam National University Hospital from 1991 to 2012 were retrospectively reviewed. RESULTS: The median age at diagnosis was 6.2 years. All patients showed evidence of marrow failure and one or more physical stigmata. Chromosome breakage tests were positive in 9 out of 11 available patients. The median follow-up duration was 69.5 months. The Kaplan-Meier (KM) survival of all patients was 83.3% at 10 years and 34.7% at 20 years, respectively. Seven patients underwent 9 stem cell transplantations (SCTs). Among them, 5 were alive by the end of the study. Ten-year KM survival after SCT was 71.4% with a median follow-up of 3.4 years. All 5 patients treated with supportive treatment alone died of infection or progression at the median age of 13.5 years, except for one with short follow-up duration. Acute leukemia developed in 2 patients at 15.4 and 18.1 years of age. Among 6 patients who are still alive, 3 had short stature and 1 developed insulin-dependent diabetes mellitus. CONCLUSION: We provide information on the long-term outcomes of FA patients in Korea. A nation-wide FA registry that includes information of the genotypes of Korean patients is required to further characterize ethnic differences and provide the best standard of care for FA patients.
Bone Marrow
;
Christianity
;
Chromosome Breakage
;
Diabetes Mellitus, Type 1
;
Diagnosis
;
Fanconi Anemia*
;
Follow-Up Studies*
;
Genotype
;
Humans
;
Jeollanam-do
;
Korea
;
Leukemia
;
Medical Records
;
Retrospective Studies
;
Standard of Care
;
Stem Cell Transplantation
;
Treatment Outcome*
7.Detection of Botulinum Neurotoxin Type A by In Vitro Bioassay Based on Endopeptidase Activity.
Yun Jeong KIM ; Joung Hee BAEK ; Jeong Hee KIM ; Bong Su KIM ; Gi eun RHIE ; Cheon Kwon YOO ; Na Ri SHIN
Journal of Bacteriology and Virology 2010;40(1):29-37
Botulinum neurotoxin type A (BoNT/A) is a metalloprotease that cleaves SNAP-25 (synaptosome-associated protein of 25 kDa), a specific cellular protein essential for neurotransmitter release. As well as mouse bioassay to detect BoNT/A, various assay methods based on its endopeptidase activity have been developed. In this study, we tried to develop a BoNT/A assay system using recombinant SNAP-25 with glutathione S-transferase (GST) tags at both termini as substrate. The recombinant GST-SNAP-25-GST with 70 kDa was expressed and purified in E. coli and synthesized N-terminal 50 kDa and C-terminal 25 kDa fragment after cleavage at the Gln(197)-Arg(198) bond by BoNT/A. To detect both fragments, we obtained rabbit antisera against peptides corresponding to the cleaved ends of each fragment. In the western blotting, the N-terminal fragment was detected by the antibody specifically recognizing the newly exposed C-terminus (corresponding to amino acid residue 191-197). This assay system was able to detect until 3.125 ng of BoNT/A, which corresponded to about 90 fold LD50 in mice. These results suggest that the in vitro endopeptidase assay developed in this study would replace others to detect BoNT/A.
Animals
;
Biological Assay
;
Blotting, Western
;
Glutathione Transferase
;
Immune Sera
;
Lethal Dose 50
;
Mice
;
Neurotransmitter Agents
;
Peptides
8.Detection of Botulinum Neurotoxin Type A by In Vitro Bioassay Based on Endopeptidase Activity.
Yun Jeong KIM ; Joung Hee BAEK ; Jeong Hee KIM ; Bong Su KIM ; Gi eun RHIE ; Cheon Kwon YOO ; Na Ri SHIN
Journal of Bacteriology and Virology 2010;40(1):29-37
Botulinum neurotoxin type A (BoNT/A) is a metalloprotease that cleaves SNAP-25 (synaptosome-associated protein of 25 kDa), a specific cellular protein essential for neurotransmitter release. As well as mouse bioassay to detect BoNT/A, various assay methods based on its endopeptidase activity have been developed. In this study, we tried to develop a BoNT/A assay system using recombinant SNAP-25 with glutathione S-transferase (GST) tags at both termini as substrate. The recombinant GST-SNAP-25-GST with 70 kDa was expressed and purified in E. coli and synthesized N-terminal 50 kDa and C-terminal 25 kDa fragment after cleavage at the Gln(197)-Arg(198) bond by BoNT/A. To detect both fragments, we obtained rabbit antisera against peptides corresponding to the cleaved ends of each fragment. In the western blotting, the N-terminal fragment was detected by the antibody specifically recognizing the newly exposed C-terminus (corresponding to amino acid residue 191-197). This assay system was able to detect until 3.125 ng of BoNT/A, which corresponded to about 90 fold LD50 in mice. These results suggest that the in vitro endopeptidase assay developed in this study would replace others to detect BoNT/A.
Animals
;
Biological Assay
;
Blotting, Western
;
Glutathione Transferase
;
Immune Sera
;
Lethal Dose 50
;
Mice
;
Neurotransmitter Agents
;
Peptides
9.Bronchial Atresia Associated with Spontaneous Pneumothorax : Report of A Case.
Yong Han YOON ; Kuk Hee SON ; Joung Taek KIM ; Wan Ki BAEK ; Kwang Ho KIM ; Kyung Hee LEE ; Hae Seung HAN
Journal of Korean Medical Science 2004;19(1):142-144
A 32-yr-old male patient with recurrent pneumothorax associated with bronchial atresia of the subsegmental branch of the posterior segmental bronchus of the right upper lobe was successfully treated with right upper lobectomy. Before surgery, the bronchial atresia with pneumothorax was suspected on the chest radiograph and CT scans, which showed the findings of bronchocele with localized hyperinflation of the right upper lobe. The examination of surgical specimen from the resected right upper lobe suggests that the cause of the recurrent pneumothorax was the rupture of the subpleural bullae in the hyperinflated lung segment distal to the atretic bronchus.
Adult
;
Bronchi/*abnormalities/pathology
;
Bronchial Diseases/*diagnosis
;
Human
;
Male
;
Pneumothorax/*diagnosis
;
Respiratory System Abnormalities/*pathology
;
Tomography, X-Ray Computed
10.Biochemical Markers as Predictors of In-Hospital Mortality in Patients with Severe Trauma: A Retrospective Cohort Study.
Ha Nee JANG ; Hyun Oh PARK ; Tae Won YANG ; Jun Ho YANG ; Sung Hwan KIM ; Seong Ho MOON ; Joung Hun BYUN ; Chung Eun LEE ; Jong Woo KIM ; Dong Hun KANG ; Kyeong Hee BAEK
Korean Journal of Critical Care Medicine 2017;32(3):240-246
BACKGROUND: Initial evaluation of injury severity in trauma patients is an important and challenging task. We aimed to assess whether easily measurable biochemical parameters (hemoglobin, pH, and prothrombin time/international normalized ratio [PT/INR]) can predict in-hospital mortality in patients with severe trauma. METHODS: This retrospective study involved review of the medical records of 315 patients with severe trauma and an injury severity score >15 who were managed at Gyeongsang National University Hospital between January 2005 and December 2015. We extracted the following data: in-hospital mortality, injury severity score, and initial hemoglobin level, pH, and PT/INR. The predictive values of these variables were compared using receiver operation characteristic curves. RESULTS: Of the 315 patients, 72 (22.9%) died. The in-hospital mortality rates of patients with hemoglobin levels <8.4 g/dl and ≥8.4 g/dl were 49.8% and 9.9%, respectively (P < 0.001). At a cutoff hemoglobin level of 8.4 g/dl, the sensitivity and specificity values for mortality were 81.9% and 86.4%, respectively. At a pH cutoff of 7.25, the sensitivity and specificity values for mortality were 66.7% and 77.8%, respectively; 66.7% of patients with a pH <7.25 died versus 22.2% with a pH ≥7.25 (P < 0.001). The in-hospital mortality rates for patients with PT/INR values ≥1.4 and <1.4 were 37.5% and 16%, respectively (P < 0.001; sensitivity, 37.5%; specificity, 84%). CONCLUSIONS: Using the suggested cutoff values, hemoglobin level, pH, and PT/INR can simply and easily be used to predict in-hospital mortality in patients with severe trauma.
Acidosis
;
Biomarkers*
;
Cohort Studies*
;
Hospital Mortality*
;
Humans
;
Hydrogen-Ion Concentration
;
Injury Severity Score
;
International Normalized Ratio
;
Medical Records
;
Mortality
;
Prothrombin
;
Retrospective Studies*
;
Sensitivity and Specificity